DOI:
10.1055/s-00000072
Seminars in Reproductive Medicine
LinksClose Window
References
LIBERTY 1: A Phase 3 randomized, double-blind, placebo-controlled efficacy & safety study of relugolix co-administered with/without estradiol and norethindrone acetate in women with heavy menstrual bleeding associated with uterine fibroids.
Available at:
https://clinicaltrials.gov/ct2/show/NCT03049735?term=Relugolix&rank=8;%20https://clinicaltri als.gov/ct2/show/NCT03103087?term=Relugolix&rank=7 . Accessed June 13, 2017
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.